Progress

An Update on Progress Towards Treating Atherosclerosis at Cyclarity – Fight Aging!

by

[ad_1] Today I’ll point out an interview with one of the Cyclarity Therapeutics founders, illustrative of the degree to which biotech companies are at the mercy of regulators once they arrive at the clinical stage of development. Cyclarity, formerly Underdog Pharmaceuticals, is a spin-out from the SENS Research Foundation, an organization that aims to … Read more

Progress Towards the Treatment of Aging as a Medical Condition – Fight Aging!

by

[ad_1] The market has been in the doldrums and it has been a tough year for fundraising, both for non-profits and biotech startups. The conferences have exhibited more of an academic focus as companies tightened belts and postponed investment rounds, while investors stayed home. Not that this halts the flow of hype for some … Read more

Accessibility by WAH